Legend Biotech Corp is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LEGN is expected to report earnings to fall 62.93% to -10 cents per share on August 29
Q2'25
Est.
$-0.10
Q1'25
Missed
by $0.06
Q4'24
Beat
by $0.09
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.24
The last earnings report on May 13 showed earnings per share of -27 cents, missing the estimate of -20 cents. With 1.51M shares outstanding, the current market capitalization sits at 5.32B.